Constellation Pharmaceuticals, A MorphoSys Company
Pharmaceutical ManufacturingView the employees at
Constellation Pharmaceuticals, A MorphoSys Company-
Rick Fritz Director, Supply Chain at Constellation Pharmaceuticals, a wholly owned subsidiary of MorphoSys
-
Palm Springs, California, United States
-
Rising Star
Susan Buttrick Senior Paralegal-
Greater Boston
-
Top 5%
Spencer Roach Director, CMC Analytical Development and Quality Control at Morphosys-
Boston, Massachusetts, United States
-
Rising Star
Allie Weidman Talent Acquisition Manager at Constellation Pharmaceuticals a MorphoSys Company-
Greater Boston
-
Rising Star
Froilan Ordonez Senior Manager Quality Systems at Constellation Pharmaceuticals (A MorphoSys company)-
Rising Star
Overview
In July 2021, MorphoSys acquired Constellation Pharmaceuticals. This transformational acquisition bolstered MorphoSys’ position as a leader in hematology and oncology and marked the beginning of an important next chapter in the company's history. MorphoSys’ mission is more life for people with cancer. As a global commercial-stage biopharmaceutical company, MorphoSys uses groundbreaking science and technologies to discover, develop, and deliver innovative cancer medicines to patients. MorphoSys is headquartered in Planegg, Germany, and has its U.S. operations anchored in Boston, Massachusetts. Read more about the acquisition here: https://www.morphosys.com/media-investors/media-center/morphosys-to-complete-transformational-acquisition-of-constellation Learn more about MorphoSys: www.MorphoSys.com
-